Menaquinone-7 supplementation to reduce vascular calcification in patients with coronary artery disease: Rationale and study protocol (VitaK-CAC Trial)

Nutrients

Volumn 7, Issue 11, 2015, Pages 8905-8915

  Vossen, Liv M ^a,b   Schurgers, Leon J ^c   van Varik, Bernard J ^a   Kietselaer, Bas L J H ^a   Vermeer, Cees ^d   Meeder, Johannes G ^e   Rahel, Braim M ^e   van Cauteren, Yvonne J M ^e   Hoffland, Ge A ^e   Rennenberg, Roger J M W ^a   Reesink, Koen D ^c   de Leeuw, Peter W ^a,b,c   Kroon, Abraham A ^a,c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Sittard Geleen Heerlen   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e VIECURI MEDICAL CENTER   (Netherlands)

Author keywords

Coronary artery calcification; Matrix gla protein; Menaquinone 7; Vascular calcification; Vitamin K2

Indexed keywords

MENAQUINONE; MENAQUINONE 7; UNCLASSIFIED DRUG; CALCIUM; CALCIUM BINDING PROTEIN; FARNOQUINONE; MATRIX GLA PROTEIN; SCLEROPROTEIN; VITAMIN; VITAMIN MK 7;

AORTA PRESSURE; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTERY COMPLIANCE; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE COURSE; DOUBLE BLIND PROCEDURE; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; ADULT; ANALOGS AND DERIVATIVES; ARTERY; CLINICAL PROTOCOL; DIETARY SUPPLEMENT; DRUG EFFECTS; HUMAN; METABOLISM; METHODOLOGY; PATHOLOGY; VASCULAR CALCIFICATION;

ADULT; ARTERIES; CALCIUM; CALCIUM-BINDING PROTEINS; CLINICAL PROTOCOLS; CORONARY ARTERY DISEASE; DIETARY SUPPLEMENTS; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; EXTRACELLULAR MATRIX PROTEINS; HUMANS; RESEARCH DESIGN; VASCULAR CALCIFICATION; VITAMIN K 2; VITAMINS;

EID: 84946061535     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7115443     Document Type: Article

References (34)

1. Henein, M.Y.; Koulaouzidis, G.; Granåsen, G.;Wiklund, U.; Guerci, A.; Schmermund, A. The natural history of coronary calcification: A meta-analysis from St Francis and EBEAT trials. Int. J. Cardiol. 2013, 168, 3944-3948. [PubMed]
2. Budoff, M.J.; Shaw, L.J.; Liu, S.T.; Weinstein, S.R.; Mosler, T.P.; Tseng, P.H.; Flores, F.R.; Callister, T.Q.; Raggi, P.; Berman, D.S. Long-term prognosis associated with coronary calcification: Observations from a registry of 25,253 patients. J. Am. Coll. Cardiol. 2007, 49, 1860-1870. [PubMed]
3. Madhavan, M.V.; Tarigopula, M.; Mintz, G.S.; Maehara, A.; Stone, G.W.; Généreux, P. Coronary artery calcification: Pathogenesis and prognostic implications. J. Am. Coll. Cardiol. 2014, 63, 1703-1714. [PubMed]
4. Luo, G.; Ducy, P.; McKee, M.D.; Pinero, G.J.; Loyer, E.; Behringer, R.R.; Karsenty, G. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997, 386, 78-81. [PubMed]
5. Schurgers, L.J.; Cranenburg, E.C.M.; Vermeer, C. Matrix Gla-protein: The calcification inhibitor in need of vitamin K. Thromb. Haemost. 2008, 100, 593-603. [PubMed]
6. Schurgers, L.J.; Uitto, J.; Reutelingsperger, C.P. Vitamin K-dependent carboxylation of matrix Gla-protein: A crucial switch to control ectopic mineralization. Trends Mol. Med. 2013, 19, 217-226. [PubMed]
7. Rennenberg, R.J.; Schurgers, L.J.; Kroon, A.A.; Stehouwer, C.D. Arterial calcifications. J. Cell Mol. Med. 2010, 14, 2203-2210. [PubMed]
8. Price, P.A.; Faus, S.A.; Williamson, M.K. Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler. Thromb. Vasc. Biol. 1998, 18, 1400-1407. [PubMed]
9. Chatrou, M.L.L.; Winckers, K.; Hackeng, T.M.; Reutelingsperger, C.P.; Schurgers, L.J. Vascular calcification: The price to pay for anticoagulation therapy with vitamin K-antagonists. Blood Rev. 2012, 26, 155-166. [PubMed]
10. Rennenberg, R.J.; van Varik, B.J.; Schurgers, L.J.; Hamulyak, K.; ten Cate, H.; Leiner, T.; Vermeer, C.; de Leeuw, P.W.; Kroon, A.A. Chronic coumarin treatment is associated with increased extracoronary arterial calcification in humans. Blood 2010, 115, 5121-5123. [PubMed]
11. Weijs, B.; Blaauw, Y.; Rennenberg, R.J.M.W.; Schurgers, L.J.; Timmermans, C.C.M.M.; Pison, L.; Nieuwlaat, R.; Hofstra, L.; Kroon, A.A.; Wildberger, J.; et al. Patients using vitamin K antagonists show increased levels of coronary calcification: An observational study in low-risk atrial fibrillation patients. Eur. Heart J. 2011, 32, 2555-2562. [PubMed]
12. Schurgers, L.J.; Teunissen, K.J.F.; Hamulyák, K.; Knapen, M.H.J.; Vik, H.; Vermeer, C. Vitamin K-containing dietary supplements: Comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood 2007, 109, 3279-3283. [PubMed]
13. Brandenburg, V.M.; Schurgers, L.J.; Kaesler, N.; Püsche, K.; van Gorp, R.H.; Leftheriotis, G.; Reinartz, S.; Koos, R.; Krüger, T. Prevention of vasculopathy by vitamin K supplementation: Can we turn fiction into fact? Atherosclerosis 2015, 240, 10-16. [PubMed]
14. McCabe, K.M.; Booth, S.L.; Fu, X.; Shobeiri, N.; Pang, J.J.; Adams, M.A.; Holden, R.M. Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease. Kidney Int. 2013, 83, 835-844. [CrossRef] [PubMed]
15. Schurgers, L.J.; Spronk, H.M.H.; Soute, B.A.M.; Schiffers, P.M.; DeMey, J.G.R.; Vermeer, C. Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats. Blood 2007, 109, 2823-2831. [CrossRef] [PubMed]
16. Krüger, T.; Oelenberg, S.; Kaesler, N.; Schurgers, L.J.; van de Sandt, A.M.; Boor, P.; Schlieper, G.; Brandenburg, V.M.; Fekete, B.C.; Veulemans, V.; et al. Warfarin induces cardiovascular damage in mice. Arterioscler. Thromb. Vasc. Biol. 2013, 33, 2618-2624. [CrossRef] [PubMed]
17. Beulens, J.W.J.; Bots, M.L.; Atsma, F.; Bartelink, M.-L.E.L.; Prokop, M.; Geleijnse, J.M.; Witteman, J.C.M.; Grobbee, D.E.; van der Schouw, Y.T. High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis 2009, 203, 489-493. [PubMed]
18. Geleijnse, J.M.; Vermeer, C.; Grobbee, D.E.; Schurgers, L.J.; Knapen, M.H.J.; van der Meer, I.M.; Hofman, A.; Witteman, J.C.M. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: The Rotterdam study. J. Nutr. 2004, 134, 3100-3105. [PubMed]
19. Shea, M.K.; O'Donnell, C.J.; Hoffmann, U.; Dallal, G.E.; Dawson-Hughes, B.; Ordovas, J.M.; Price, P.A.; Williamson, M.K.; Booth, S.L. Vitamin K supplementation and progression of coronary artery calcium in older men and women. Am. J. Clin. Nutr. 2009, 89, 1799-1807. [CrossRef] [PubMed]
20. Braam, L.A.J.L.M.; Hoeks, A.P.G.; Brouns, F.; Hamulyák, K.; Gerichhausen, M.J.W.; Vermeer, C. Beneficial effects of vitamins D and K on the elastic properties of the vessel wall in postmenopausal women: A follow-up study. Thromb. Haemost. 2004, 91, 373-380. [CrossRef] [PubMed]
21. Shea, M.K.; Holden, R.M. Vitamin K status and vascular calcification: Evidence from observational and clinical studies. Adv. Nutr. 2012, 3, 158-165. [CrossRef] [PubMed]
22. Dalmeijer, G.W.; van der Schouw, Y.T.; Magdeleyns, E.; Ahmed, N.; Vermeer, C.; Beulens, J.W.J. The effect of menaquinone-7 supplementation on circulating species of matrix Gla protein. Atherosclerosis 2012, 225, 397-402. [CrossRef] [PubMed]
23. Knapen, M.H.J.; Braam, L.A.J.L.M.; Drummen, N.E.; Bekers, O.; Hoeks, A.P.G.; Vermeer, C. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. A double-blind randomised clinical trial. Thromb. Haemost. 2015, 113, 1135-1144. [CrossRef] [PubMed]
24. Gast, G.C.M.; de Roos, N.M.; Sluijs, I.; Bots, M.L.; Beulens, J.W.J.; Geleijnse, J.M.; Witteman, J.C.; Grobbee, D.E.; Peeters, P.H.M.; van der Schouw, Y.T. A high menaquinone intake reduces the incidence of coronary heart disease. Nutr. Metab. Cardiovasc. Dis. 2009, 19, 504-510. [CrossRef] [PubMed]
25. Schurgers, L.J.; Shearer, M.J.; Hamulyák, K.; Stöcklin, E.; Vermeer, C. Effect of vitamin K intake on the stability of oral anticoagulant treatment: Dose-response relationships in healthy subjects. Blood 2004, 104, 2682-2689. [CrossRef] [PubMed]
26. Schurgers, L.J. Vitamin K: Key vitamin in controlling vascular calcification in chronic kidney disease. Kidney Int. 2013, 83, 782-784. [CrossRef] [PubMed]
27. Agatston, A.S.; Janowitz, W.R.; Hildner, F.J.; Zusmer, N.R.; Viamonte, M.; Detrano, R. Quantification of coronary artery calcium using ultrafast computed tomography. J. Am. Coll. Cardiol. 1990, 15, 827-832. [CrossRef]
28. Austen,W.G.; Edwards, J.E.; Frye, R.L.; Gensini, G.G.; Gott, V.L.; Griffith, L.S.; McGoon, D.C.; Murphy, M.L.; Roe, B.B. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975, 51, 5-40. [CrossRef] [PubMed]
29. Versteylen, M.O.; Kietselaer, B.L.; Dagnelie, P.C.; Joosen, I.A.; Dedic, A.; Raaijmakers, R.H.;Wildberger, J.E.; Nieman, K.; Crijns, H.J.; Niessen, W.J.; et al. Additive value of semiautomated quantification of coronary artery disease using cardiac computed tomographic angiography to predict future acute coronary syndrome. J. Am. Coll. Cardiol. 2013, 61, 2296-2305. [CrossRef] [PubMed]
30. Van Bortel, L.M.; Laurent, S.; Boutouyrie, P.; Chowienczyk, P.; Cruickshank, J.K.; de Backer, T.; Filipovsky, J.; Huybrechts, S.; Mattace-Raso, F.U.S.; Protogerou, A.D.; et al. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J. Hypertens. 2012, 30, 445-448. [CrossRef] [PubMed]
31. Willekes, C.; Brands, P.J.; Willigers, J.M.; Hoeks, A.P.G.; Reneman, R.S. Assessment of local differences in intima-media thickness in the human common carotid artery. J. Vasc. Res. 1999, 36, 222-228. [CrossRef] [PubMed]
32. Westenfeld, R.; Krueger, T.; Schlieper, G.; Cranenburg, E.C.M.; Magdeleyns, E.J.; Heidenreich, S.; Holzmann, S.; Vermeer, C.; Jahnen-Dechent,W.; Ketteler, M.; et al. Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: A randomized trial. Am. J. Kidney Dis. 2012, 59, 186-195. [CrossRef] [PubMed]
33. Theuwissen, E.; Cranenburg, E.C.; Knapen, M.H.; Magdeleyns, E.J.; Teunissen, K.J.; Schurgers, L.J.; Smit, E.; Vermeer, C. Low-dose menaquinone-7 supplementation improved extra-hepatic vitamin K status, but had no effect on thrombin generation in healthy subjects. Br. J. Nutr. 2012, 108, 1652-1657. [CrossRef] [PubMed]
34. Scott, N.W.; McPherson, G.C.; Ramsay, C.R.; Campbell, M.K. The method of minimization for allocation to clinical trials: A review. Control. Clin. Trials 2002, 23, 662-674. [CrossRef]